Results 141 to 150 of about 82,677 (285)

Follow-up of patients with contrast-induced nephropathy

, 2006
Richard Solomon, Brendan J. Barrett
openalex   +1 more source

Contrast-induced nephropathy [PDF]

, 2009
David Zemánek
openalex   +1 more source

Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis

British Journal of Pharmacology, EarlyView.
Background and Purpose Myocardial fibrosis (MF), a hallmark of structural cardiac remodelling, drives disease progression across most forms of heart failure and plays a central role in heart failure with preserved ejection fraction (HFpEF). Despite its clinical relevance, effective treatments remain scarce.
Sheyla Barrado‐Ballestero, Sarah Torp Yttergren, Max Hahn, Marie Biviano Rosenkilde, Ditte Marie Jensen, Michael Christensen, Louise Thisted, Heidi Lindgreen Holmberg, Geoffrey Teixeira, Tor Biering‐Sørensen, Casper Gravesen Salinas, Urmas Roostalu   +11 more
wiley   +1 more source

N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial [PDF]

, 2009
Manouchehr Amini, Mojtaba Salarifar, Alireza Amirbaigloo, Farzad Masoudkabir, Fatemeh Esfahani   +4 more
openalex   +1 more source

Targeting ROCK1/YAP1 Axis Ameliorates Inflammation‐Induced Prostatic Hyperplasia via Stabilising SIRT1‐Dependent Mitochondrial Dynamics

Cell Proliferation, EarlyView.
Prostate‐specific YAP1 overexpression induces pathological BPH phenogenesis. Targeting ROCK1/YAP1 with fasudil and verteporfin alleviates inflammatory BPH lesions. YAP1 orchestrates mitochondrial dysfunction and oxidative stress via suppressing SIRT1 function.
Dongxu Lin, Pengyu Wei, Mengyang Zhang, Kang Li, Lina Li, Zhipeng Li, Changcheng Luo, Wenbo Kuang, Kai Cui, Zhong Chen   +9 more
wiley   +1 more source

Contrast induced nephropathy in cardiac interventions

Indian Heart Journal, 2014
Vicar Jan, Raese Khan, Hilal Rather, Imran Hafeez, M. Jehangir   +4 more
doaj   +1 more source

Incidence of Contrast-induced Nephropathy in Intensive Care Patients Undergoing Computerised Tomography and Prevalence of Risk Factors [PDF]

, 2009
Asrar Rashid, Jorge Brieva, Barrie Stokes   +2 more
openalex   +1 more source

Eplerenone improves kidney function and cardiac performance in obese male mice

Diabetic Medicine, EarlyView.
Abstract Aims Renin‐angiotensin‐aldosterone system (RAAS) activation mediates obesity‐associated cardiorenal dysfunction. Due to an incomplete understanding of the molecular mechanisms, the clinical use of RAAS antagonism in obesity‐associated cardiometabolic complications remains uncertain.
Ayman K. Banah, Bingxue Qi, Ryan Koh, Alexander Lawlor, Tianzhen Wang, Vishal Musale, Joanne Mains, Colin E. Murdoch, Li Kang   +8 more
wiley   +1 more source

Modifying the Risk of Contrast‐Associated Acute Kidney Injury in Percutaneous Coronary Interventions and Transcatheter Aortic Valve Implantations

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Briggs S. Carhart, Meagan E. Stabler, Jeremiah R. Brown   +2 more
doaj   +1 more source

Pathophysiology of type 2 diabetes: A focus on the metabolic differences among southeast Asian, Chinese and Indian populations and how this impacts treatment

Diabetes, Obesity and Metabolism, EarlyView.
Abstract The prevalence of type 2 diabetes has been rising in China, India and Southeast Asia for decades, challenging their healthcare systems. With region‐specific determinants such as genetics, lifestyle transition and early‐life environment, people with type 2 diabetes showed their unique phenotypes, including being, on average, younger in age ...
Yuzi Cao, Indah Widyahening, Xiaodong Sun, Sheyu Li   +3 more
wiley   +1 more source